Home » Topics » Regulatory

Regulatory
RSS

FDA approves Rexulti for schizophrenia and major depressive disorder

July 13, 2015

No Comments

FDA approves Entresto to reduce risk of cardiovascular death and heart failure hospitalization

July 8, 2015

No Comments

Olanedine antiseptic approved in Japan

July 7, 2015

No Comments

Strensiq receives first approval in Japan for hypophosphatasia

July 7, 2015

No Comments

Acoalan approved in Japan

July 6, 2015

No Comments

FDA grants approval to Orkambi for cystic fibrosis

July 3, 2015

No Comments

FDA approves Tuxarin ER

July 3, 2015

No Comments

European approval of Simponi for non-radiographic axial spondyloarthritis

June 29, 2015

No Comments

Radicut approved in Japan for amyotrophic lateral sclerosis

June 29, 2015

No Comments

FDA approves Rapamune for lymphangioleiomyomatosis

June 2, 2015

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

FDA approves Rexulti for schizophrenia and major depressive disorder

FDA approves Entresto to reduce risk of cardiovascular death and heart failure hospitalization

Olanedine antiseptic approved in Japan

Strensiq receives first approval in Japan for hypophosphatasia

Acoalan approved in Japan

FDA grants approval to Orkambi for cystic fibrosis

FDA approves Tuxarin ER

European approval of Simponi for non-radiographic axial spondyloarthritis

Radicut approved in Japan for amyotrophic lateral sclerosis

FDA approves Rapamune for lymphangioleiomyomatosis

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Experimental mRNA gene therapy suppresses preeclampsia in mice

Cell mapping yields clues to metabolic health in obese individuals

Regulatory RSS

Regulatory
RSS